<!DOCTYPE html>

<html lang="en">

        <head>
                <!-- Page information -->
                <meta charset="UTF-8" />
                <meta name="node_id" content="01.1. Asthma">
                <meta name="viewport" content="width=device-width, initial-scale=1.0" />
                <link rel="shortcut icon" href="/favicon.ico" />

                <!-- Set title -->
                <title>Pulmonary Critical Care Notes</title>

                <!-- Includes -->
                <link rel="stylesheet" href="/obs.html/static/mermaid.css" />
                <link rel="stylesheet" href="/obs.html/static/main.css" />
                <script src="/obs.html/static/mermaid.min.js"></script> 
                
<link rel="stylesheet" href="/obs.html/static/callouts.css" />
<link rel="stylesheet" href="/obs.html/static/graph.css" />
<script src="/obs.html/static/dirtree.js" /></script>


                <!-- Onload tweaks -->
                <script>
                        const CURRENT_NODE = '01.1. Asthma';
                </script>
        </head>

<body onload="LoadPage();">
        <div class="flex_col">
                <div id="header" class="header">
                        <div id="header_flex" class="flex_row">
                                <a href="/index.html" id="homelink" title="Clear screen and go to homepage">Pulmonary Critical Care Notes</a>
                                <div class="navbar-button" onclick="toggle('navbar', 'flex')">
                                        ≡
                                </div>
                                <div id="navbar" class="navbar">
                                <a class="navbar-link" href="/Pulmonary Medicine/Pulmonary Medicine.html" title="Pulmonary">Pulmonary</a>
<a class="navbar-link" href="/Critical Care Medicine/Critical Care Medicine.html" title="Critical Care">Critical Care</a>
                                        <div class="icon-tray">
                                                
                                                <div style="width:1.6rem; height:1.6rem; float:right; margin-right:0.2rem">
                                                        <a href="/obs.html/tags/index.html" title="Open tag view">
                                                                <img src = "/obs.html/static/hashtag.svg" alt="RSS Feed link"/>
                                                        </a>
                                                </div>
                                                        <div style="width: calc(1.6rem - 6px); height: calc(1.6rem - 6px); border: 3px solid #f0f0f0; margin-right:0.2rem; float:right;">
            <a id="dirtree_link" class="system-link" href="/obs.html/dir_index.html" title="View directory tree">
                    <img src = "/obs.html/static/dirtree.svg" style="width: 14px; padding: 3px;" alt="Directory tree link"/>
            </a>
        </div>
                                                        <div class="graph_header_div">
            <a id="graph_link" class="system-link" href="/obs.html/graph/index.html?node=01.1. Asthma" title="Open fullpage Graph">
                    <img class="graph_header_div_svg" src = "/obs.html/static/graph.svg" alt="Open fullpage Graph"/>
            </a>
        </div>
                                        </div>
                                </div>
                        </div>
                </div>
                <div class="flex_row">
                        <div id="left_pane"></div>
                        <div class="container">
                                        <h1 id="general-information">General Information</h1>
<div class="toc">
<ul>
<li><a href="#general-information" class="anchor-link">General Information</a></li>
<li><a href="#associated-anatomy-physiology" class="anchor-link">Associated Anatomy &amp; Physiology</a></li>
<li><a href="#epidemiology" class="anchor-link">Epidemiology</a></li>
<li><a href="#etiology-pathogenesis-pathology" class="anchor-link">Etiology, Pathogenesis &amp; Pathology</a><ul>
<li><a href="#biology" class="anchor-link">Biology</a><ul>
<li><a href="#genetics" class="anchor-link">Genetics</a></li>
</ul>
</li>
<li><a href="#risk-factors" class="anchor-link">Risk Factors</a></li>
<li><a href="#natural-history" class="anchor-link">Natural History</a></li>
<li><a href="#pathogenesis" class="anchor-link">Pathogenesis</a><ul>
<li><a href="#mechanisms-of-asthma" class="anchor-link">Mechanisms of Asthma</a></li>
<li><a href="#phenotypes" class="anchor-link">Phenotypes</a></li>
<li><a href="#mechanisms-of-asthma-exacerbation" class="anchor-link">Mechanisms of Asthma Exacerbation</a></li>
</ul>
</li>
<li><a href="#pathology" class="anchor-link">Pathology</a></li>
</ul>
</li>
<li><a href="#pathophysiology" class="anchor-link">Pathophysiology</a></li>
<li><a href="#diagnosis" class="anchor-link">Diagnosis</a><ul>
<li><a href="#evaluation" class="anchor-link">Evaluation</a></li>
<li><a href="#special-types-phenotypes-of-asthma" class="anchor-link">Special Types &amp; Phenotypes of Asthma</a><ul>
<li><a href="#aspirin-sensitive-asthma" class="anchor-link">Aspirin-Sensitive Asthma</a></li>
<li><a href="#exercise-induced-asthma" class="anchor-link">Exercise-Induced Asthma</a></li>
<li><a href="#eosinophilic-th2-high-asthma" class="anchor-link">Eosinophilic Th2-High Asthma</a></li>
<li><a href="#cough-variant-asthma-other-special-types" class="anchor-link">Cough Variant Asthma &amp; Other Special Types</a></li>
</ul>
</li>
<li><a href="#asthma-mimics" class="anchor-link">Asthma Mimics</a><ul>
<li><a href="#paradoxical-vocal-fold-motion-inducible-laryngeal-obstruction" class="anchor-link">Paradoxical Vocal Fold Motion (Inducible Laryngeal Obstruction)</a></li>
<li><a href="#genetic" class="anchor-link">Genetic</a><ul>
<li><a href="#cystic-fibrosis" class="anchor-link">Cystic Fibrosis</a></li>
<li><a href="#-1-antitrypsin-disease" class="anchor-link">α-1 Antitrypsin Disease</a></li>
<li><a href="#primary-ciliary-dyskinesia" class="anchor-link">Primary Ciliary Dyskinesia</a></li>
</ul>
</li>
<li><a href="#non-genetic" class="anchor-link">Non-Genetic</a></li>
<li><a href="#hypereosinophilic-lofflers-syndrome-other-parasitic-infections" class="anchor-link">Hypereosinophilic Loffler's Syndrome &amp; Other Parasitic Infections</a></li>
<li><a href="#infiltrative-airway-processes" class="anchor-link">Infiltrative Airway Processes</a><ul>
<li><a href="#granulomatous" class="anchor-link">Granulomatous</a></li>
<li><a href="#amyloidosis" class="anchor-link">Amyloidosis</a></li>
<li><a href="#others" class="anchor-link">Others</a></li>
</ul>
</li>
<li><a href="#heart-failure" class="anchor-link">Heart Failure</a></li>
<li><a href="#central-airway-obstruction" class="anchor-link">Central Airway Obstruction</a></li>
</ul>
</li>
<li><a href="#diseases-associated-with-asthma" class="anchor-link">Diseases Associated with Asthma</a><ul>
<li><a href="#allergic-bronchopulmonary-aspergillosis-and-fungosis" class="anchor-link">Allergic Bronchopulmonary Aspergillosis and Fungosis</a></li>
<li><a href="#eosinophilic-granulomatosis-with-polyangiitis" class="anchor-link">Eosinophilic Granulomatosis with Polyangiitis</a></li>
</ul>
</li>
<li><a href="#exacerbation" class="anchor-link">Exacerbation</a></li>
</ul>
</li>
<li><a href="#management" class="anchor-link">Management</a><ul>
<li><a href="#severity-stepped-care" class="anchor-link">Severity &amp; Stepped Care</a><ul>
<li><a href="#mild-to-moderate" class="anchor-link">Mild to Moderate</a></li>
<li><a href="#severe" class="anchor-link">Severe</a></li>
<li><a href="#asthma-in-pregnancy" class="anchor-link">Asthma in Pregnancy</a></li>
<li><a href="#perioperative-care" class="anchor-link">Perioperative Care</a></li>
<li><a href="#complications-of-care" class="anchor-link">Complications of Care</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<ul>
<li>Definition: heterogenous &amp; chronic inflammatory disorder of airways characterized by <strong>hyperreactivity (hyperresponsiveness) of the airways</strong> causing airway narrowing due to exaggerated response of airway smooth muscle contraction (due to a wide variety of stimuli) leading to <strong>reversible episodes of bronchoconstriction</strong> and therefore <strong>variable expiratory airflow limitation</strong>   <ul>
<li>hyperresponsiveness of airways due to exaggerated smooth muscle contraction —&gt; bronchoconstriction that is reversible —&gt; variable expiratory airflow limitation   </li>
</ul>
</li>
<li>Exacerbations happen interspersed between intervals of diminished symptoms or symptom-free period   </li>
</ul>
<h1 id="associated-anatomy-physiology">Associated Anatomy &amp; Physiology</h1>
<p><a href="/Pulmonary Medicine/11. Respiratory Anatomy &amp; Physiology/11.01. The Airways &amp; Alveoli/11.01.1. The Airways.html">The Airways</a>   </p>
<h1 id="epidemiology">Epidemiology</h1>
<ul>
<li>Highest prevalence and severity in children (9.3%), low socioeconomic level (12.4%), and specific minorities (Puerto Ricans [18.8%] &amp; black, non-Hispanic Americans [11.9%])   </li>
<li>Most prevalent chronic respiratory disease worldwide   <ul>
<li>Estimated global prevalence of 358 million (2015)   </li>
<li>25 million Americans have current Asthma   <ul>
<li>US Prevalence 7.8% (2019)   <ul>
<li>Increased over time -- 7.3% in 2001   </li>
</ul>
</li>
<li>Prevalence by Sex   <ul>
<li>Overall F &gt; M except in childhood where M &gt; F   </li>
</ul>
</li>
<li>Prevalence by race/ethnicity   <ul>
<li>Overall: PR &gt; Black &gt; White &gt; Hispanic &gt; Mexican   </li>
<li>Adults: PR &gt; Black &gt; White &gt; Hispanic &gt; Mexican   </li>
<li>Children: <em>Black</em> &gt; <em>PR</em> &gt; White &amp; Hispanic &gt; Mexican   </li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>250K asthma-related deaths each year worldwide   <ul>
<li>In US, 14.4 per 1 mil (1980) → 21.9 per 1 mil (1995) → 17.2 per 1 mil (1999) → 15 per 1 mil (2009)   </li>
<li>Disproportionately affects blacks (38.7 per 1 mil) and those of PR heritage (40.1 per 1 mil)   </li>
<li>Unknown the real cause of this   </li>
</ul>
</li>
<li>Associated Conditions   <ul>
<li>Comorbidities which may aggravate asthma   <ul>
<li>Allergic rhinitis   </li>
<li>Sinusitis   </li>
<li>GERD   <ul>
<li>Patients w/ asthma at increased risk of developing GERD — CASE-CONTROL STUDY: <a href="http://pubmed.ncbi.nlm.nih.gov/16002920?dopt=Abstract" class="external-link">Chest 2005 Jul;128(1):85</a>   </li>
<li>GERD and Asthma may be associated in adults — SYSTEMATIC REVIEW: <a href="http://pubmed.ncbi.nlm.nih.gov/17682001?dopt=Abstract" class="external-link">Gut 2007 Dec;56(12):1654</a>   </li>
<li>GERD common in difficult-to-control asthma (found in 75% of 52 patients) but GERD treatment may not improve asthma — <a href="http://pubmed.ncbi.nlm.nih.gov/15821199?dopt=Abstract" class="external-link">Chest 2005 Apr;127(4):1227</a>   </li>
</ul>
</li>
<li>Nasal polyps   </li>
<li>Allergic bronchopulmonary aspergillosis   </li>
<li>Obesity   </li>
<li>Depression and Anxiety   <ul>
<li>Depression and anxiety may be more common in adolescents with asthma — SYSTEMATIC REVIEW: <a href="http://pubmed.ncbi.nlm.nih.gov/22957535?dopt=Abstract" class="external-link">Pediatr Allergy Immunol 2012 Dec;23(8):707</a>   </li>
<li>Asthma associated with suicide attempts — CROSS-SECTIONAL STUDY: <a href="http://pubmed.ncbi.nlm.nih.gov/18517075?dopt=Abstract" class="external-link">Ann Allergy Asthma Immunol 2008 May;100(5):439</a>   </li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h1 id="etiology-pathogenesis-pathology">Etiology, Pathogenesis &amp; Pathology</h1>
<h2 id="biology">Biology</h2>
<h3 id="genetics">Genetics</h3>
<p><img alt="" src="/Pulmonary%20Medicine/01.%20Obstructive%20Lung%20Disease/attachments/2022-04-24%20Untitled.png" />   </p>
<h2 id="risk-factors">Risk Factors</h2>
<ul>
<li>Strongest risk factor = family history of allergy — estimates of heritability range from 35-70% (higher for early-onset asthma)   <ul>
<li>inc risk of developing allergic rhinitis   </li>
<li>inc risk of developing asthma   </li>
<li><strong>Serum IgE correlates strongly with bronchial hyperresponsiveness</strong>   </li>
<li>Association with gene variants at Ch 17q21 locus — a/w childhood asthma not adult-onset; genes GSDMB &amp; ORMDL3 -- specific to childhood onset disease   </li>
</ul>
</li>
<li>Other risk factors   <ul>
<li>Specific allergens: House dust mites, dog and cat dander, cockroach — controlling these is part of the treatment of asthma   </li>
<li>Early life infections   <ul>
<li>Hygiene hypothesis —protective effect   <ul>
<li>rise in allergies in children is an unintended consequence of the success of domestic hygiene in reducing the rate of infections or exposure to bacterial products in early childhood   </li>
<li>essentially due to the improved hygiene you have less exposure to allergens and bacteria (exposure to this is supposed to promote Th1 immunity (cellular defense) → which is responsible for blunting Th2 immunity)   </li>
</ul>
</li>
<li>Increase risk for wheezing illnesses and asthma over time as a result of viral respiratory infections (RSV and Rhinovirus)   <ul>
<li>exposure early in life leads to asthma   </li>
<li>unclear whether its a direct causation or whether it unmasks a predisposition to predominant Th2 like responses   </li>
<li>if those children develop lower respiratory infections due to RSV and Rhino they are at 3-4-fold risk of subsequent wheezing during early school years   </li>
<li>Early wheezing = age &lt;3; persistent wheezing = present at age 6   <ul>
<li>Early wheezing — a/w RSV and Rhino → can become persistent (this is due to atopy) or can be transient (this is due to maternal smoking)   </li>
<li>Late-onset wheezing — starts at age 6 — also due to atopy   </li>
</ul>
</li>
</ul>
</li>
<li>children who lived in farms had a lower prevalence   </li>
</ul>
</li>
<li>Atypical Bacterial Infections   <ul>
<li>Mycoplasma and Chlamydia pneumoniae   <ul>
<li>infect the airway epithelium → stimulate local inflammatory reactions   </li>
<li>more common in the airway of patients with chronic stable asthma   </li>
<li>a/w increase in tissue mast cells   </li>
</ul>
</li>
<li>lower airway biospecimens from asthmatics show abnormalities in the composition of bacterial microbiota, especially Proteobacteria (which include H. influenzae, Pseudomonas, Neisseria, Burkholderia species, and Enterobacteriaceae species.   <ul>
<li>Notably, Proteobacterial species promote neutrophilic inflammation, and there is now great interest in whether specific microbial pathogens drive specific subtypes of asthma (such as neutrophilic asthma)   </li>
</ul>
</li>
</ul>
</li>
<li>Intrauterine exposures   <ul>
<li>growth rates — both high and low   </li>
<li>dietary vitamins D and E deficiency; vitamin D plays a role in immunoregulation   </li>
<li>exposure to microbial products   </li>
<li>parental smoking   </li>
<li>parental stress   </li>
</ul>
</li>
<li>Perinatal Risk Factors   <ul>
<li>prematurity   </li>
<li>chorioamnionitis   </li>
</ul>
</li>
</ul>
</li>
<li>Early Childhood Risk Factors   <ul>
<li>shorter breastfeeding period   </li>
<li>obesity   </li>
<li>absence of older siblings or daycare attendance (i.e. exposure to other children)   </li>
<li>antibiotic use   </li>
<li>acetaminophen use (esp when given in 1st year of life; ? dose dependent)   </li>
<li>Bacteroides fragilis colonization at age 3 weeks is a/w increased risk of asthma   </li>
<li>upper airway colonization in infants by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis predicts later development of asthma   </li>
<li>Air pollution   <ul>
<li>no data to suggest that air pollution can contribute to the development of asthma   </li>
<li>however increased prevalence in those with proximity to heavy automobile traffic due to exposure of particulate matter and NO2   </li>
</ul>
</li>
<li>Occupational exposures   <ul>
<li>accounts for 17% of adult-onset asthma   </li>
<li>can be immunologically mediated sensitization to occupational agents — sensitizer-induced occupational asthma   </li>
<li>or exposure to high concentrations of irritant compounds — irritant-induced occupational asthma   </li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="natural-history">Natural History</h2>
<ul>
<li>Atopic/Allergic March   <ul>
<li>pattern of atopic dz during infancy and childhood that begins with atopic dermatitis or eczema in the 1st year of life (+/- food allergy) then progresses to development of rhinoconjunctivitis then asthma later in life   </li>
</ul>
</li>
<li>Teenage Years   <ul>
<li>starting in puberty, asthma changes from male predominance to female predominance (which continues into adulthood)   </li>
<li>? hormonal component   </li>
</ul>
</li>
<li>Remission   <ul>
<li>R/F a/w greater likelihood of persistence into adulthood — sensitization to house dust mites, lower FEV1, airway hyperresponsiveness, female gender, and smoking at the age of 21   </li>
<li>data to suggest that the inflammatory response really never goes away even in patients in "remission" (elevated Fraction of NO, bronchial bx show eosinophils, T cells, mast cells, and increased subepithelial fibrosis)   </li>
</ul>
</li>
<li>Progressive Airflow Obstruction   <ul>
<li>Deposition of collagen and growth of vessels, smooth muscle, secretory cells and glands → progressive narrowing of airways in chronic asthma   </li>
</ul>
</li>
<li>Adulthood   <ul>
<li>many had symptoms as a child   </li>
<li>can be de novo — usually after an acute URI   </li>
</ul>
</li>
<li>Elderly   <ul>
<li>if asthma presents as an adult it will continue later in life   </li>
<li>elderly patients more likely to have fixed airway obstruction compared to children   </li>
</ul>
</li>
</ul>
<h2 id="pathogenesis">Pathogenesis</h2>
<h3 id="mechanisms-of-asthma">Mechanisms of Asthma</h3>
<p><img alt="" src="/Pulmonary Medicine/01. Obstructive Lung Disease/attachments/2022-04-24 Asthma_Pathogenesis_(1).png" />   </p>
<h3 id="phenotypes">Phenotypes</h3>
<ul>
<li>What we call asthma may not represent a single disease process but rather the summation of a number of pathogenetic pathways (endotypes) that have differences in expression (phenotype) w/ common features being airway inflammation and episodic bronchoconstriction   <ul>
<li>Phenotype — observable characteristics that result from a combination of hereditary and environmental influences.   </li>
<li>Endotype — distinct mechanistic/molecular pathway leading to a certain phenotype   </li>
<li>Biomarker — a measurable indicator of presence or severity of a disease state   </li>
<li><img alt="" src="/Pulmonary Medicine/01. Obstructive Lung Disease/attachments/2022-04-24 Asthma_(1).png" />   </li>
</ul>
</li>
<li>Th2-High   <ul>
<li>increased expression of IL-13 &amp; IL-5   </li>
<li>exaggerated airway hyperresponsiveness — methacholine   </li>
<li>higher serum IgE levels   </li>
<li>higher eosinophils (blood and BAL eosinophilia) (&gt;3%)   </li>
<li>increased thickness of fibrosis below the airway epithelial BM   </li>
<li>Increased MUC5AC/MUC5B ratio → increased expression in goblet cells   </li>
<li>Increased number of intra-epithelial mast cells   </li>
</ul>
</li>
<li>Th2-Low   <ul>
<li>i.e. non-Th2   </li>
<li>driven by Th1 &amp; Th17 → airflow obstruction &amp; exacerbation   </li>
<li>Th1   <ul>
<li>IFN-gamma dependent airway hyperresponsiveness → corticosteroid resistance   </li>
</ul>
</li>
<li>Th17   <ul>
<li>IL-17, IL-21, IL-22 but not IFN-gamma or IL-4   </li>
<li>most parenchymal cells (including airway epithelial cells) express receptors for Th17 cytokines → IL-17 → production of pro-inflammatory factors (IL-16, IL-1, TNF-a &amp; IL-8 (which attracts neutrophils))   <ul>
<li>IL-17 → increases epithelial production of secreted mucins   </li>
</ul>
</li>
<li>Th17 → steroid resistance   </li>
</ul>
</li>
<li><strong>Airway inflammation does not play a dominant role in clinical manifestations in Th2-low rather a result of abnormal ASM response</strong> (contraction by histamine and ACh)   </li>
<li>Paucigranulocytic asthma — most common phenotype in stable asthma; 20% can be severe/refractory   </li>
</ul>
</li>
<li>Polymorphism in:   <ul>
<li>IL-4, IL-13 genes — allergies and IgE   </li>
<li>CD14 &amp; TLR genes — farming and endotoxin exposure   </li>
<li>TGF-B1, MCP-1 — fibrosis/remodeling   </li>
<li>Gene for the B chain of the high-affinity receptor for IgE (FCER1B) — allergies   </li>
<li>B-receptor (Arg/Arg) and glucocorticoid polymorphism determine heterogeneity in treatment response —&gt; mutation causes down regulation of B2 receptors decreasing response to treatment   </li>
</ul>
</li>
</ul>
<h3 id="mechanisms-of-asthma-exacerbation">Mechanisms of Asthma Exacerbation</h3>
<ul>
<li>exacerbations represents acute on chronic worsening of airflow obstruction due to worsening airway smooth muscle contraction, airway wall edema, and luminal obstruction with mucus   </li>
<li>repeated airway remodeling → susceptibility to acute reductions in airflow   </li>
<li>changes in epithelium → increase mucin stores → mucus hypersecretion → more hyperreactive   </li>
<li>changes in airway smooth muscle → concentric smooth muscle contraction → more hyperreactive   </li>
<li>changes in blood vessels → increased permeability → vulnerable to exaggerated airway responses to inhaled environmental insults → worsening mucosal edema → more hyperreactive   </li>
</ul>
<h2 id="pathology">Pathology</h2>
<ul>
<li>structural changes in epithelium and submucosa   </li>
<li>Edema (from Nitric Oxide) and cellular infiltrates within the bronchial wall, esp with eosinophils and lymphocytes   </li>
<li>Epithelial Changes   <ul>
<li>Main Changes   <ul>
<li>Goblet Cell Metaplasia &amp; Hyperplasia   <ul>
<li>increasing amount of gel-forming mucins that are stored in the airway epithelium   </li>
</ul>
</li>
<li>Epithelial damage, with a "fragile" appearance of the epithelium and detachment of surface epithelial cells from basal cells   </li>
</ul>
</li>
<li>Less Common Changes   <ul>
<li>Desquamation — acute severe asthma exacerbation (not chronic stable asthma)   </li>
<li>Squamous metaplasia — usually seen in smoking-related lung injury not asthma   </li>
</ul>
</li>
</ul>
</li>
<li>Airway Mucus Changes   <ul>
<li>Higher mucin concentration than normal   <ul>
<li>MUC5AC upregulation in epithelial cells and MUC5B downregulation   </li>
</ul>
</li>
<li>Presence of albumin — prominent protein in asthma   <ol>
<li>reflects increased vascular permeability (esp in acute exacerbations)   </li>
<li>albumin + other proteins + mucin → increase mucus viscosity   </li>
</ol>
</li>
</ul>
</li>
<li>
<p>Subepithelial Fibrosis   </p>
<ul>
<li>Increased amounts of types I, III, and V collagen + fibronectin and tenascin → deposited immediately underneath the epithelium (which means underneath the basement membrane)   </li>
<li>Recall BM is made up of collage IV and laminin so this is underneath the BM layer   </li>
<li>source of these collagens are the epithelial cells and myofibroblasts (which are increased in number in asthma)   </li>
<li>more prominent in Type 2 Eosinophilic asthma   </li>
<li>Due to the stiffness of the matrix, it causes persistent activation of overlying epithelial cells and smooth muscle cells → bronchoconstriction   </li>
<li>Airway Smooth Muscle Cells   </li>
<li>Mild-moderate asthma — hyperplasia of ASM   </li>
<li>Severe asthma — hypertrophy + hyperplasia of ASM   </li>
<li>increased shortening → affects elastance   </li>
<li>Blood vessels   </li>
<li>Quantity and size increases   </li>
<li>Increase in vascular volume → mucosal swelling → narrowing of airway lumen   </li>
<li>all due to increased permeability from vasodilation   </li>
<li>Airway Pathology in Fatal Cases of Asthma   </li>
<li>severe concentric smooth muscle contractions + extensive mucus plugging → segmental and subsegmental lung collapse   </li>
<li>greater airway wall thickening, ASM hypertrophy (leads to bumps on the airway) and submucosal gland hypertrophy   </li>
</ul>
<h1 id="pathophysiology">Pathophysiology</h1>
<p><img alt="" src="/Pulmonary%20Medicine/01.%20Obstructive%20Lung%20Disease/attachments/2022-04-24%20Pathophysiology_of_Asthma.png" />   </p>
<h1 id="diagnosis">Diagnosis</h1>
<h2 id="evaluation">Evaluation</h2>
<h2 id="special-types-phenotypes-of-asthma">Special Types &amp; Phenotypes of Asthma</h2>
<h3 id="aspirin-sensitive-asthma">Aspirin-Sensitive Asthma</h3>
<h3 id="exercise-induced-asthma">Exercise-Induced Asthma</h3>
<h3 id="eosinophilic-th2-high-asthma">Eosinophilic Th2-High Asthma</h3>
<h3 id="cough-variant-asthma-other-special-types">Cough Variant Asthma &amp; Other Special Types</h3>
<h2 id="asthma-mimics">Asthma Mimics</h2>
<h3 id="paradoxical-vocal-fold-motion-inducible-laryngeal-obstruction">Paradoxical Vocal Fold Motion (Inducible Laryngeal Obstruction)</h3>
<h3 id="genetic">Genetic</h3>
<h4 id="cystic-fibrosis"><a href="/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Cystic Fibrosis.html">Cystic Fibrosis</a></h4>
<h4 id="-1-antitrypsin-disease">α-1 Antitrypsin Disease</h4>
<h4 id="primary-ciliary-dyskinesia">Primary Ciliary Dyskinesia</h4>
<h3 id="non-genetic">Non-Genetic</h3>
<h3 id="hypereosinophilic-lofflers-syndrome-other-parasitic-infections">Hypereosinophilic Loffler's Syndrome &amp; Other Parasitic Infections</h3>
<h3 id="infiltrative-airway-processes">Infiltrative Airway Processes</h3>
<h4 id="granulomatous">Granulomatous</h4>
<h4 id="amyloidosis">Amyloidosis</h4>
<h4 id="others">Others</h4>
<h3 id="heart-failure">Heart Failure</h3>
<h3 id="central-airway-obstruction"><a href="/Pulmonary Medicine/01. Obstructive Lung Disease/Index/Central Airway Obstruction.html">Central Airway Obstruction</a></h3>
<h2 id="diseases-associated-with-asthma">Diseases Associated with Asthma</h2>
<h3 id="allergic-bronchopulmonary-aspergillosis-and-fungosis">Allergic Bronchopulmonary Aspergillosis and Fungosis</h3>
<h3 id="eosinophilic-granulomatosis-with-polyangiitis">Eosinophilic Granulomatosis with Polyangiitis</h3>
<h2 id="exacerbation">Exacerbation</h2>
<h1 id="management">Management</h1>
<h2 id="severity-stepped-care">Severity &amp; Stepped Care</h2>
<h3 id="mild-to-moderate">Mild to Moderate</h3>
<h3 id="severe">Severe</h3>
<h3 id="asthma-in-pregnancy">Asthma in Pregnancy</h3>
<h3 id="perioperative-care">Perioperative Care</h3>
<h3 id="complications-of-care">Complications of Care</h3>
</li>
</ul><h2>Backlinks</h2>
<ul>
	<li><a class="backlink" href="/Pulmonary Medicine/01. Obstructive Lung Disease/01. Obstructive Lung Disease.html">01. Obstructive Lung Disease</a></li>
</ul>
<!-- <div class="graph">
    <svg class="graph_svg" id="A318932613252831484141174635045919503365{level}"></svg>
    <button class="graph_button" id="B318932613252831484141174635045919503365{level}" level="{level}" onclick="run('318932613252831484141174635045919503365'+this.level, '01.1. Asthma');">Show Graph</button>
</div>
<script src="/obs.html/static/graph.js" type="text/javascript"></script>

 -->
 <script src="/obs.html/static/graph.js" type="text/javascript"></script>

<div class="graph">
    <div id="A318932613252831484141174635045919503365{level}" class="graph_div"></div>
    <button class="graph_button" id="B318932613252831484141174635045919503365{level}" level="{level}" onclick="run('318932613252831484141174635045919503365'+this.level, '01.1. Asthma');">Show Graph</button>
</div>


<script src="//unpkg.com/3d-force-graph"></script>
<script>
    function grapher(args) {
        window.Graph = ForceGraph3D()
            (args.graph_container)
            .jsonUrl(args.data)
            .width(args.width)
            .height(args.height)
            .nodeLabel('id')
            .linkDirectionalParticles("value")
            .linkDirectionalParticleSpeed(0.010)
            .linkDirectionalParticleWidth(2.0)
            .nodeColor(node => {
                if (node.id == current_node_id){
                    return '#ff0000'
                }
                let isConnected = false;
                node.links.forEach(link => {
                    if (link == current_node_id){
                        isConnected = true;
                    }
                })
                if (isConnected){
                    return '#f7be49';
                }
                return '#ffffff'
            })
            .linkColor(link => {
                if (link.source == current_node_id || link.target == current_node_id){
                    return '#ff0000'
                }
                return '#dadada'
            })
            .linkOpacity(0.3)
            .onNodeClick(node => {
                args.node = node;
                graph_left_click(args)()
            })
            .onNodeRightClick(node => {
                args.node = node;
                graph_right_click(args)()
            });
    }
</script>


                        <!-- end content -->
                        </div>
                        <div id="right_pane"></div>
                </div>
        </div>

<script src="/obs.html/static/obsidian.js" type="text/javascript"></script>

</body>
</html>
